{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T03:03:21Z","timestamp":1778209401903,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ygyno.2021.03.012","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T03:11:34Z","timestamp":1615691494000},"page":"710-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States"],"prefix":"10.1016","volume":"161","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Nusbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10023","key":"10.1016\/j.ygyno.2021.03.012_bb0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"9823","key":"10.1016\/j.ygyno.2021.03.012_bb0015","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","article-title":"Contemporary management of endometrial cancer","volume":"379","author":"Wright","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0020","author":"Uterine Neoplasms"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2020.03.031","article-title":"Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer","volume":"133","author":"Matsuo","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0030","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e8","article-title":"A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma","volume":"30","author":"Takahashi","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2018.02.012","article-title":"Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer","volume":"149","author":"Matsuo","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.03.012_bb0040","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e34","article-title":"Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy","volume":"29","author":"Tate","year":"2018","journal-title":"J. Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.03.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.03.011","article-title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","volume":"145","author":"Scott","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.03.012_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/IGC.0000000000000072","article-title":"Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?: the remaining controversy and review of the literature","volume":"24","author":"Shiozaki","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3802\/jgo.2014.25.1.30","article-title":"FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype","volume":"25","author":"Haltia","year":"2014","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/AOG.0b013e3181a94568","article-title":"Stage IIIA endometrial carcinoma: outcome and predictors of survival","volume":"114","author":"Bansal","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.03.012_bb0075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10269-008-0898-z","article-title":"Positive peritoneal cytology and its prognostic value in endometrioid adenocancer confined to the uterus","volume":"10","author":"Metindir","year":"2008","journal-title":"Oncologie."},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ygyno.2006.08.027","article-title":"The prognostic significance of positive peritoneal cytology and adnexal\/serosal metastasis in stage IIIA endometrial cancer","volume":"104","author":"Havrilesky","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2006.03.003","article-title":"Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?","volume":"103","author":"Saga","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.03.012_bb0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","volume":"91","author":"Tebeu","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2020.07.010","article-title":"Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer","volume":"159","author":"Matsuo","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.03.012_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2021.01.007","article-title":"Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer","author":"Takenaka","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.03.012_bb0115","author":"National Cancer Institute's The Surveillance"},{"issue":"11","key":"10.1016\/j.ygyno.2021.03.012_bb0120","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","article-title":"Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute","volume":"76","author":"Zippin","year":"1995","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2021.03.012_bb0125","author":"National Cancer Registrars Association"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0130","author":"Corpus Carcinoma"},{"issue":"120 Suppl 23","key":"10.1016\/j.ygyno.2021.03.012_bb0135","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1002\/cncr.29054","article-title":"Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2","author":"Jamison","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0140","author":"International classification of disease for oncology"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0145","author":"American Joint Committee on Cancer"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0150","series-title":"Gynecologic Oncology Group Surgical Procedures Manual","author":"Whitney","year":"2009"},{"issue":"28","key":"10.1016\/j.ygyno.2021.03.012_bb0155","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"issue":"7624","key":"10.1016\/j.ygyno.2021.03.012_bb0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.03.012_bb0165","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-021-09900-4","article-title":"Association between adjuvant therapy and survival in stage II-III endometrial cancer: influence of malignant peritoneal cytology","author":"Matsuo","year":"2021","journal-title":"Ann. Surg. Oncol."},{"issue":"26","key":"10.1016\/j.ygyno.2021.03.012_bb0170","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ygyno.2017.02.004","article-title":"Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy","volume":"145","author":"Matsuo","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0180","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e18","article-title":"Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms","volume":"31","author":"Yamagami","year":"2020","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.03.012_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo","year":"2016","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.03.012_bb0190","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.03.012_bb0195","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/AOG.0000000000000636","article-title":"Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome","volume":"125","author":"Matsuo","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.03.012_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2020.08.004","article-title":"Malignant peritoneal cytology in endometrial cancer: areas of unmet need for evidence","author":"Matsuo","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.03.012_bb0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajog.2020.10.045","article-title":"Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology","volume":"224","author":"Matsuo","year":"2021","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:48:13Z","timestamp":1715820493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0090825821002328"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}